Category Archives for Pre-Myeloma

Is a Diagnosis of “Plasma Cell Dyscrasia” a Diagnosis of MGUS, SMM or MM?

“Plasma cell dyscrasias (MGUS, SMM, MM) are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow. Multiple myeloma is the most

Continue reading

Can MGUS Patient Predict Progression to Multiple Myeloma?

“Individuals with low-risk/intermediate-risk MGUS can convert to high-risk MGUS and progress to multiple myeloma within five years…” I think it makes sense that serum immune markers of

Continue reading

Slow/Stop SMM’s March Toward Full-Blown Multiple Myeloma

“Hyperdiploid-myeloma is associated with male sex, kappa immunoglobulin subtype, symptomatic bone disease and better survival compared to nonhyperdiploid-MM Hi David-I contacted you a couple months

Continue reading

Multiple Myeloma Cancer Coaching- Non-Hodgkin Lymphoma w/ MGUS

“The results showed that curcumin strongly inhibited proliferation of Raji cells, (lymphoma) for Raji cells was 22.8 +/- 1.82 micromol/L and curcumin induced Raji cell apoptosis in a time- and dose-dependent

Continue reading

Monoclonal Gammopathy of Undetermined Significance (MGUS) and HPV

What Does It Mean for MGUS and HPV to be “Associated?” Actionable Non-Toxic Therapy is For the Pre-Myeloma Patient- The study linked and excerpted below cites a small study of MGUS patients,

Continue reading

Low But Persistent Risk of MGUS

Interestingly, the risk for MGUS progression in the IgM group — 10.8 times higher than the general population — was higher than that seen in non-IgM patients — 5.7 times higher than the general population. If

Continue reading

MGUS-IgG Kappa Diagnosis and Freaked Out!

The rate of transformation of monoclonal gammopathy of undetermined significancer (MGUS) to MM or other lymphoproliferative diseases is 1% per year Dear Cancer Coach- I have Monoclonal Gammopathy of Undetermined

Continue reading

Risk of Progression for Smoldering Multiple Myeloma is Reduced…at what cost?

“Lenalidomide (Revlimid) induced a 72% reduction in the risk of progression to symptomatic disease in patients with smoldering multiple myeloma at 3 years” The challenge with pre-myeloma, Monoclonal

Continue reading

Monoclonal Gammopathy of Undetermined Significance (MGUS) Nerve Pain

Peripheral Neuropathy (PN) as Symptom of Monoclonal Gammopathy of Undetermined Significance (MGUS) Monoclonal Gammmopathy of Undetermined Significance at a glance- click the illustration below: Diagnostic

Continue reading

MGUS, PPI’s, Barrett’s Esophagus and Bone Health

Esophageal involvement (barrett’s esophagus) by multiple myelomas is uncommon in the English literature. Here we report an extremely rare involvement in MM/MGUS Hi David- I was diagnosed with Barrett’s

Continue reading
1 2 3 5